Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

9 treatments under study, led by Early Luteal Phase

Research Leaders

7 sponsors active, led by LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro

Related Conditions

Often studied with 17 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed1
Enrolling By Invitation1
Unknown1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Early Luteal Phase1
  • Gonadotropins Fsh Or Fshlh1
  • Medroxyprogesterone Acetate1
  • Human Chorionic Gonadotropin Hcg1
  • Ovarian Stimulation With Menstruation Or After Ovulation1

Active Sponsors

  • LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro1
  • ART Fertility Clinics LLC1
  • Theramex1
  • Ginefiv1
  • Parc de Salut Mar1

Top Investigators

Related Conditions

  • Female Infertility1
  • Infertility Drugs1
  • Ivf Outcome1
  • Infertility Ivf Patients1
  • Oocyte1

Activity Timeline